NIHR Investment in a UK-Wide Commercial Research Delivery Network
Monday, 1 September 2025, 02:49
NIHR Investment Overview
The NIHR investment announced the establishment of a UK-wide commercial research delivery network, which is set to transform the landscape of clinical trials.
Key Objectives
- Enhancing collaboration among stakeholders
- Boosting innovation in research
- Improving access to clinical trials for patients
Funding Support
This initiative is backed by the Voluntary Scheme for Branded Medicine Pricing, Access and Growth (VPAG), contributing up to £300 million to stimulate commercial research.
Impact on Healthcare
By facilitating a more integrated network of research delivery, this investment is poised to enhance the efficiency of the healthcare system in the UK and provide more options for patients.
This article was prepared using information from open sources in accordance with the principles of Ethical Policy. The editorial team is not responsible for absolute accuracy, as it relies on data from the sources referenced.